Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis Vaccines and Diagnostics Ltd)


Welcome to the PulseAid listing for the Influenza A (H1N1) 2009 Monovalent Vaccine drug offered from Novartis Vaccines and Diagnostics Ltd. This pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Novartis Vaccines and Diagnostics Ltd
NON-PROPRIETARY NAME: Influenza A (H1N1) 2009 Monovalent Vaccine
SUBSTANCE NAME: INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-09-15
END MARKETING DATE: 0000-00-00


Influenza A (H1N1) 2009 Monovalent Vaccine VACCINE Details:

Item DescriptionInfluenza A (H1N1) 2009 Monovalent Vaccine from Novartis Vaccines and Diagnostics Ltd
LABELER NAME: Novartis Vaccines and Diagnostics Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: 15(ug/.5mL)
START MARKETING DATE: 2009-09-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66521-200_04366dc0-ba66-11de-a487-0002a5d5c51b
PRODUCT NDC: 66521-200
APPLICATION NUMBER: BLA103837

Other INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Vaccines and Diagnostics LtdInfluenza A (H1N1) 2009 Monovalent Vaccine